LeMaitre Vascular, Inc. Q3 2013 Sales $15.3mm (+12%)

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BURLINGTON, Mass., Oct. 29, 2013 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, today reported Q3 2013 financial results. The Company posted sales of $15.3mm and operating income of $0.8mm. The Company also announced a $0.03/share dividend and provided Q4 2013 and full-year 2013 guidance.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC